PHAT 8-K 2026-07-30

Phathom Pharmaceuticals, Inc. (PHAT) 8-K dated 2026-07-30 — accession 0001193125-26-324865. This URL is the filing, not the PHAT hub.

Phathom Pharmaceuticals, Inc. (PHAT) is a biotechnology company listed on US.

Phathom Pharmaceuticals, Inc. filed a 8-K on 2026-07-30. Accession 0001193125-26-324865.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported PHAT revenue for 2025-12-31 was $175.1M. Net income was -$221.2M. Revenue was up 216.9% from 2024-12-31 to 2025-12-31. PHAT currently screens at market cap $622.7M.

Not investment advice. The PHAT SEC hub lists recent forms. The stock page is the research view.